Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Bluestem API
Toronto, Ontario, Canada
- Ownership
- Private
- Development stage
- Other
01
Overview
Bluestem holds multiple Health Canada research licenses for psilocybin, has begun commercial sales of GMP botanical psilocybin for approved research, and is preparing for further scale-up with a proprietary automated cultivation system and digital patient service platforms. The company is early-stage and focused on building infrastructure and partnerships.[1][5]
- Therapeutic areas
- NeurologyPsychiatry
- Modalities
- Small moleculeBotanical/plant-derived drug
- Industry
- Biotech
02
Partnerships
PurMinds NeuroPharma
Beyond the preview
Go deeper on Bluestem API.
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Licensing & deals
Full profile accessExplore licensing agreements, acquisitions, and the assets behind each deal.
- Partners
- Deal terms
- Milestones
Funding history
Full profile accessTrace financing activity and the investors behind a company’s development.
- Funding rounds
- Investors
- Capital raised
Competitive landscape
Full profile accessCompare peer pipelines by target, modality, and therapeutic area.
- Peer companies
- Targets
- Pipeline overlap
Technologies & patents
Full profile accessExplore technology platforms and the patent landscape around relevant assets.
- Platforms
- Patents
- Assignees
Research & analysis
Full profile accessConnect company news and source material to the questions you’re investigating.
- Company news
- Sources
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on Bluestem API.